Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Circulation. 2004 Feb 17;109(6):701-5. doi: 10.1161/01.CIR.0000116202.41966.D4. Epub 2004 Jan 26.

Abstract

Background: The US Food and Drug Administration recently issued a warning of subacute thrombosis and hypersensitivity reactions to sirolimus-eluting stents (Cypher). The cause and incidence of these events have not been determined.

Methods and results: We present findings of a 58-year-old man who died of late stent thrombosis 18 months after receiving 2 Cypher stents for unstable angina. Although angiographic and intravascular ultrasound results at 8 months demonstrated the absence of neointimal formation, vessel enlargement was present. An autopsy showed aneurysmal dilation of the stented arterial segments with a severe localized hypersensitivity reaction consisting predominantly of T lymphocytes and eosinophils.

Conclusions: The known pharmacokinetic elution profile of Cypher stents and the presence of polymer fragments surrounded by giant cells and eosinophils suggest that a reaction to the polymer may have caused late stent thrombosis. Careful long-term follow-up of patients with vessel enlargement after Cypher stent placement is recommended.

Publication types

  • Case Reports

MeSH terms

  • Angina, Unstable / diagnostic imaging
  • Angina, Unstable / therapy
  • Coronary Angiography
  • Coronary Thrombosis / etiology*
  • Coronary Thrombosis / pathology
  • Drug Delivery Systems / adverse effects*
  • Fatal Outcome
  • Humans
  • Hypersensitivity / etiology*
  • Hypersensitivity / pathology
  • Male
  • Middle Aged
  • Myocardial Infarction / pathology
  • Sirolimus / administration & dosage*
  • Sirolimus / therapeutic use
  • Stents / adverse effects*
  • Ultrasonography

Substances

  • Sirolimus